Literature DB >> 15177785

Novel tracing paradigms--genetically engineered herpesviruses as tools for mapping functional circuits within the CNS: present status and future prospects.

Zsolt Boldogköi1, Attila Sík, Adám Dénes, Anikó Reichart, József Toldi, Ida Gerendai, Krisztina J Kovács, Miklós Palkovits.   

Abstract

The mammalian CNS is composed of an extremely complex meshwork of highly ordered interconnections among billions of neurons. To understand the diverse functions of this neuronal network we need to differentiate between functionally related and nonrelated elements. A powerful labeling method for defining intricate neural circuits is based on the utilization of neurotropic herpesviruses, including pseudorabies virus and herpes simplex virus type 1. The recent development of genetically engineered tracing viruses can open the way toward the conception of novel tract-tracing paradigms. These new-generation tracing viruses may facilitate the clarification of problems, which were inaccessible to earlier approaches. This article first presents a concise review of the general aspects of neuroanatomical tracing protocols. Subsequently, it discusses the molecular biology of alpha-herpesviruses, and the genetic manipulation and gene expression techniques that are utilized for the construction of virus-based tracers. Finally, it describes the current utilization of genetically modified herpesviruses for circuit analysis, and the future directions in their potential applications.

Entities:  

Mesh:

Year:  2004        PMID: 15177785     DOI: 10.1016/j.pneurobio.2004.03.010

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  40 in total

1.  Intracranial landmarks and other techniques to further improve the precision of stereotaxic tracer injections.

Authors:  Zsolt I Kovács; Miklós Palkovits
Journal:  Exp Brain Res       Date:  2010-10-27       Impact factor: 1.972

2.  Synaptic and extrasynaptic transmission of kidney-related neurons in the rostral ventrolateral medulla.

Authors:  Hong Gao; Andrei V Derbenev
Journal:  J Neurophysiol       Date:  2013-09-11       Impact factor: 2.714

3.  Core-controlled polymorphism in virus-like particles.

Authors:  Jingchuan Sun; Chris DuFort; Marie-Christine Daniel; Ayaluru Murali; Chao Chen; Kodetham Gopinath; Barry Stein; Mrinmoy De; Vincent M Rotello; Andreas Holzenburg; C Cheng Kao; Bogdan Dragnea
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

4.  UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture.

Authors:  Jennifer A Schwartz; Elizabeth E Brittle; Ashley E Reynolds; Lynn W Enquist; Saul J Silverstein
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 5.  Recent findings on the organization of central nervous system structures involved in the innervation of endocrine glands and other organs; observations obtained by the transneuronal viral double-labeling technique.

Authors:  Ida Gerendai; Ida E Tóth; Zsolt Boldogkoi; Béla Halász
Journal:  Endocrine       Date:  2009-05-06       Impact factor: 3.633

6.  Controlling viral capsid assembly with templating.

Authors:  Michael F Hagan
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2008-05-08

7.  A theory for viral capsid assembly around electrostatic cores.

Authors:  Michael F Hagan
Journal:  J Chem Phys       Date:  2009-03-21       Impact factor: 3.488

8.  The neuroinvasive profiles of H129 (herpes simplex virus type 1) recombinants with putative anterograde-only transneuronal spread properties.

Authors:  Gregory J Wojaczynski; Esteban A Engel; Karina E Steren; Lynn W Enquist; J Patrick Card
Journal:  Brain Struct Funct       Date:  2014-03-02       Impact factor: 3.270

9.  Mechanisms of size control and polymorphism in viral capsid assembly.

Authors:  Oren M Elrad; Michael F Hagan
Journal:  Nano Lett       Date:  2008-10-25       Impact factor: 11.189

Review 10.  The alpha-herpesviruses: molecular pathfinders in nervous system circuits.

Authors:  Mats I Ekstrand; L W Enquist; Lisa E Pomeranz
Journal:  Trends Mol Med       Date:  2008-02-14       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.